PFSCF News 1.0500 Prometic Life Scienc (PFSCF)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Prometic Life Scienc (PFSCF) 1.0500 $PFSCF

ProMetic's PBI-4050 Delivers New Positive Preclinical Results in Liver Fibrosis and Liver Cancer
Marketwire - Thu Apr 10, 6:01AM CDT
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF), ("ProMetic" or the "Corporation" presented new pre-clinical data at the 2014 annual meeting of the European Association for the Study of the Liver ("EASL" currently being held in London, UK. The new data supports the claim that PBI-4050's anti-fibrotic activity could also address various liver conditions such as non-alcoholic steatohepatitis ("NASH" , a condition affecting 2% to 5% of Americans, as well as liver cancer.

ProMetic's PBI-4050 Shown to Reduce Blood Glucose and Kidney Fibrosis in Preclinical Models of Human Type II Diabetes and Kidney Disease
Marketwire - Thu Apr 03, 8:04AM CDT
ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF), ("ProMetic" or the "Corporation" presented new pre-clinical data at the 2014 International Society of Nephrology ("lSN" : Nexus Symposium - New Era of Drug Discovery and Clinical Trials in Kidney Disease held in Bergamo, Italy on April 3-6, 2014.

ProMetic Reports Successful Pre-IND Meeting with the FDA
Marketwire - Wed Apr 02, 6:02AM CDT
ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("ProMetic" or the "Corporation" announced today that it had a successful Pre-Investigational New Drug ("Pre-IND) meeting with the US Food and Drug Administration ("FDA" for a plasma-derived biopharmaceutical currently under development under the NantPro, LLC joint venture.

ProMetic Reports its 2013 Fourth Quarter and Financial Year End Results and Business Highlights
Marketwire Canada - Wed Mar 26, 4:11PM CDT
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX FSCF) ("ProMetic" or the "Corporation" today reported revenues of $5.1 million and $20.6 million for the quarter and year ended December 31, 2013 respectively. This compares to revenues of $8.3 million and $23.3 million for the quarter and year ended December 31, 2012 respectively.

ProMetic to Report its Fourth Quarter and Year End 2013 Financial Results and Hold Conference Call/Webcast
Marketwire - Fri Mar 21, 11:55AM CDT
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF) ("ProMetic" or the "Corporation" today announced that it will report its financial results for the fourth quarter and fiscal year ended December 31, 2013 on Wednesday March 26, 2014 after market trading hours.

ProMetic Receives $3.2 Million Via Loan Repayment
Marketwire - Tue Mar 11, 5:31AM CDT
ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF), ("ProMetic" or the "Corporation" announced today that it has received approximately $3.2 million via the repayment of the amended and restated loan entered into in March, 2010 by ProMetic and InvHealth Holding Inc. ("Invhealth" , a corporation wholly-owned and controlled by Mr. Pierre Laurin, President and Chief Executing Officer of ProMetic (the "Loan" .

Avivagen Announces Nomination of New Director Mr. G.F. Kym Anthony Standing for Election
ACCESSWIRE - Fri Feb 28, 7:02AM CST
OTTAWA, ONTARIO / February 28, 2014 / ACCESSWIRE / Avivagen Inc. (TSXV:VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces the nomination of a new Director, Mr. G.F. Kym Anthony, and the retirement of its current Chairman, Mr. Jacques Brault.

ProMetic Enters Into $1.6 Million Development Agreement With New Client
Marketwire - Thu Feb 06, 12:25PM CST
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF), ("ProMetic" or the "Corporation" announced today that its UK based subsidiary, ProMetic BioSciences Ltd. ("PBL" , has entered into a new agreement with a leading vaccines company, for the development of an affinity adsorbent and associated purification process for the production of a novel vaccine product.

ProMetic Announces the Appointment of its New Chief Medical Officer
Marketwire - Thu Feb 06, 5:31AM CST
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF), ("ProMetic" or the "Corporation" announced today the appointment of Dr. John Moran as its new Chief Medical Officer ("CMO" , effective as of March 1st, 2014.

ProMetic Achieves Key Plasma Protein Manufacturing Milestone
Marketwire - Wed Jan 22, 6:01AM CST
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF), ("ProMetic" or the "Corporation" announced today the achievement of the second manufacturing milestone related to its strategic agreement ("Agreement" with Hematech Biotherapeutics Inc. ("Hematech" triggering a $1.0 million payment to ProMetic. This milestone was achieved following the successful completion of the first large-scale production run at its ProMetic BioProduction Inc. ("PBP" plasma purification facility located in Laval, Quebec.

Bioseparation Systems for Global Biopharmaceutical Markets: 2013 Report
M2 - Tue Dec 17, 5:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/8b887q/bioseparation) has announced the addition of the "Bioseparation Systems for Global Biopharmaceutical Markets: 2013 Report" report to their offering. Bioseparations systems can be categorized into three types: chromatography, membranes/filters and centrifuges. The demand for single use products is increasing and fueling growth of the global bioseparations market. New biosimilars are driving the increase in global biomanufacturing capacity. Blockbuster biologics are going off patent, leaving the market open for developing and manufacturing low cost biosimilars. This report provides market revenue size and growth rates for North America, Europe, Asia-Pacific (Japan, South Korea, Singapore) and the emerging BRICs (Brazil, Russia, India, China). Single-use products, manufacturing capacity, applications of bioseparations in downstream processing, downstream processing bottlenecks and emerging bioseparations technologies are covered in detail. The report also analyzes the competitive landscape, including key players' strengths and weaknesses, opportunities, gaps and industry trends. Detailed tables and charts with sales forecasts and marketshare data are also included. Scope of the Report - Single use products - Manufacturing capacity - Applications of bioseparations in downstream processing - Downstream processing bottlenecks - Emerging bioseparations technologies - Manufacturing capacity by biopharmaceutical company, CMO and region Key Topics Covered: 1. Introduction 2. Overview 3. Biologics in the Development Phase 4. Bioseparations Products and Systems 5. The Biopharmaceutical Manufacturing Process 6. Bioseparation Processes Used for Biologics Manufacturing 7. Global Bioseparation Market Analysis 8. The Global Bioseparations Market by Region 9. Competitive Landscape 10. Industry Analysis 11. Single-Use Bioseparations Systems and Products 12. Chromatography for Bioseparations 13. Filters and Membranes Used for Bioseparations 14. Industrial Centrifuges for Downstream Processing 15. Company Profiles Companies Mentioned: - Agilent Technologies - Alfa Wassermann Separation Technologies - Applied Biosystems Corporation (Life Technologies) - Asahi Kasei - Bio-Rad Laboratories - Carr Centritech - Celeros - DSM Biologics - Dow Chemical Company - Flottweg Separations Technology - G-Con Manufacturing - GE Healthcare Life Sciences - GEA Westfalia Separator Group - Hitachi Koki Co LTD - Knauer - Kronlab (YMC Europe) - Life Technologies - M Cuno - Meissner Filtration Products, Inc - Merck Millipore - Novasep Life Sciences Manufacturing Solutions - Novavax - NuSep Holdings Ltd - Pall Corporation - ProMetic Life Sciences Inc - Sartorius Stedim Biotech - SciLog - Spectrum Laboratories - Tarpon Biosystems - Tosoh Bioscience - US Filter Control Systems, Inc - Waters Corporation For more information visit http://www.researchandmarkets.com/research/8b...separation
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 92

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
Arbor Realty's Loan Mess Meets a Dividend Shutdown

Updated Category News Views 89

A dividend suspension lands differently when the loan book is already coughing up smoke. Arbor Realty Trust’s latest disclosed numbers are not the sort that investors can shrug off as one ugly quarter and forget by Friday. The company reported a third-quarter 2026 GAAP net loss of $85.4 million, suspended its quarterly cash dividend effective immediately, and described...

Continue Reading
Banks Face a Choice: Retreat or Fund Climate Resilience

Updated Category News Views 93

A flooded field can turn a prudent loan book into a social retreat overnight. That is the uncomfortable nerve in the Global Alliance for Banking on Values paper unveiled at COP31 in Antalya on November 19, 2026. Banks have become very practiced at mapping physical climate exposure, raising prices, tightening standards and stepping away. Fine, risk discipline matters. But...

Continue Reading
Harbour BioMed's LET003 Gets China's IND Green Light

Updated Category News Views 84

Muscle loss has become the awkward fact sitting beside every blockbuster obesity headline. Harbour BioMed's Nov. 18 announcement that China's National Medical Products Administration accepted its IND application for LET003 matters because the company is aiming directly at that problem: losing fat without giving away too much lean mass along the way. Acceptance Opens a...

Continue Reading
Kuaishou’s AI Push Meets a Brutal Earnings Reality

Updated Category News Views 91

Kuaishou just put a very expensive wrinkle in its AI story. The third-quarter figures are not a minor wobble: revenue dropped 11.1% year over year to RMB31.6 billion, gross margin slid from 54.7% to 48.2%, and the company swung from a RMB4.5 billion profit to a RMB959 million loss. For holders of 01024, that is the sort of earnings release that demands less daydreaming...

Continue Reading
FAMID's Six-Month IVDR Win Opens Europe's Market Door

Updated Category News Views 75

A six-month regulatory sprint is the sort of result that makes a crowded diagnostics field pause and squint. DNV has issued an IVDR certificate to FAMID Biomedical Technology for its E7 Oncoprotein Rapid Test Kit, a Class C in vitro diagnostic intended to aid diagnosis of cervical epithelial cell lesions through detection of HPV E7 oncoprotein in cervical cell samples....

Continue Reading
Northstar's December Test: Metrics Over More Promises

Updated Category News Views 11

A shingle recycler earns its stripes when the machinery behaves, not when the slide deck does. Northstar Clean Technologies is putting Empower Calgary under a brighter light on December 1, pairing its third-quarter 2026 results with a comprehensive production update and a new set of operating metrics. For shareholders, especially those following OTCQB:ROOOF, this is the...

Continue Reading
T. Rowe Price Expands Teams Across 12 Fund Strategies

Updated Category News Views 35

A Quiet Personnel Shift With Real Stakes Twelve strategy changes may sound like administrative wallpaper, but asset managers live and die by who makes the calls. T. Rowe Price is broadening portfolio-management teams across equity and fixed-income offerings while insisting that each strategy's philosophy, process, and risk limits remain intact. Fine. That is the stated...

Continue Reading
Rare Stellar Merger Validates RIT Theory in Nature

Updated Category News Views 82

One star swallowed another’s orbit, and astronomy finally caught the evidence. That is the plain-English punch of the observation called AT 2025abao in the Andromeda Galaxy, and it is a meaningful one for Jason Nordhaus and his colleagues at Rochester Institute of Technology. On Nov. 18, research published in Nature validated a scenario Nordhaus’s team had predicted...

Continue Reading
Vision Marine's Cash Cleanup Meets a Hard Reality Ahead

Updated Category News Views 72

A boat dealer slashing debt by $27.5 million deserves a nod, even when the rest of the ledger still makes your eyebrows climb. Vision Marine Technologies turned fiscal 2026 into a working-capital cleanup job: inventory came down hard, floor-plan financing nearly vanished, and operating cash flow finally turned positive. For NASDAQ:VMAR, that is real progress. It is not,...

Continue Reading

Top 5 Most Recently Viewed Articles

MediPharm Labs: Strategic Steps for Enhanced Shareholder Value

Updated Category News Views 141

MediPharm Labs Announces Proxy Materials for Shareholder Meetings Toronto - MediPharm Labs Corp. (TSX: LABS) has filed comprehensive Management Information Circulars and proxy materials ahead of its upcoming Annual and Special Meeting. This meeting, pivotal for the future direction of the company, is set for June 16. Shareholders can expect to receive these materials...

Continue Reading
PRM Revitalizes Its Online Presence with Stylish Relaunch

Updated Category News Views 215

PRM Elevates Your Style with an Online Revamp In an exciting development for fashion enthusiasts, PRM, a trendsetting brand where luxury meets urban flair, has unveiled a newly revamped online store. This relaunch marks a significant transformation spearheaded with the expert assistance from industry professionals, aiming to elevate its presence in the European fashion...

Continue Reading
Why Companies Choose Altcoins Like ETH, SOL, and XRP Over Bitcoin

Updated Category News Views 188

Why Companies Are Opting for Altcoins in Their Treasury Strategies In recent times, publicly traded companies have increasingly embraced a wider array of cryptocurrencies beyond Bitcoin. Names like Ethereum, Solana, XRP, and Binance Coin are becoming commonplace in corporate treasuries. This trend reflects a significant shift in how businesses perceive and integrate these...

Continue Reading
Epson Launches Arm-Compatible Drivers for Advanced Scanning Solutions

Updated Category News Views 346

Epson's Commitment to Innovation in Scanning Technology Epson America, the top-selling scanner brand in the U.S., is proud to unveil Arm-compatible drivers for Windows in its extensive lineup of scanners. This groundbreaking step positions Epson as a leader in the scanning technology space, tailored for industries such as healthcare, finance, and enterprise solutions....

Continue Reading
Harnessing AI for Transformation: A Framework for Organizations

Updated Category News Views 240

Harnessing AI for Transformation: A Comprehensive Framework Artificial intelligence (AI) stands as one of the most revolutionary technologies in today’s world, yet many organizations grapple with moving from mere experiments to having a concrete enterprise strategy. A leading research and advisory firm has released a blueprint aimed at guiding both IT and business...

Continue Reading